Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
13 December 1984Website:
http://www.icadmed.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 17:22:24 GMTDividend
Analysts recommendations
Institutional Ownership
ICAD Latest News
NASHUA, N.H., June 04, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, announced today the Company will present at the MedInvest MedTech, AI & Digital Healthcare Conference on June 11-12, 2024 in San Francisco, CA. Dana Brown, Chief Executive Officer, and Eric Lonnqvist, Chief Financial Officer, of iCAD, Inc., will participate in one-on-one meetings with investors at the event.
iCAD, Inc. (ICAD) Q4 2023 Earnings Call Transcript
NASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes, announced today the Company will release financial results for the fourth quarter and full year 2023 financials after the market close, and host a conference call at 4:30 PM Eastern Time on Tuesday, March 12, 2024.
Penny stocks are usually small-cap stocks, and small-cap stocks typically tend to perform the best during the early stages of the business cycle when the economy is recovering and growing fairly rapidly. Multi-billionaire investor Ken Fisher has indicated that we are in the early stages of the business cycle, and I agree with him.
Vodacom Group Limited (OTCPK:VODAF) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Leonor Faber - Assistant to Chief Executive Officer Dana Brown - President & Chief Executive Officer Eric Lonnqvist - Chief Financial Officer Conference Call Participants Per Ostlund - Craig-Hallum Capital Operator Good day, everyone and welcome to the iCAD, Inc. Third Quarter 2023 Earnings Call. At this time, all participants have been placed in a listen-only mode and we will open the floor for your questions and comments after the presentation.
NASHUA, N.H., Oct. 30, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, today announced that it will release financial results for the third quarter ended September 30, 2023, after the market close, and host a conference call at 4:30 PM Eastern Time on Monday, November 13, 2023.
iCAD, Inc. (NASDAQ:ICAD ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Jessica Burns – Head-Global Communications Dana Brown – President and Chief Executive Officer Eric Lonnqvist – Chief Financial Officer Conference Call Participants Per Ostlund – Craig-Hallum Capital Sam Eiber – BTIG Yale Jen – Laidlaw & Company Frank Takkinen – Lake Street Capital Operator Greetings. Welcome to the iCAD Inc. Second Quarter 2023 Earnings Call.
iCAD, Inc. (NASDAQ:ICAD ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Linnell Faber - Executive Assistant to CEO Dana Brown - President and CEO Eric Lonnqvist - CFO Conference Call Participants Per Ostlund - Craig Hallum Marie Thibault - BTIG Yale Jen - Laidlaw & Company Frank Takkinen - Lake Street Capital Markets Francois Brisebois - Oppenheimer Operator Good day, everyone, and welcome to the iCAD, Inc. First Quarter 2023 Earnings Call. At this time all participants have been placed on a listen-only mode and we will open the floor for your questions and comments after the presentation.
Icad (ICAD) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.14 per share a year ago.
iCAD, Inc. (NASDAQ:ICAD ) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Dana Brown - President, Chief Executive Officer Dan Shea - Interim Chief Financial Officer Linnell Faber - Executive Assistant to Chief Executive Officer Conference Call Participants Per Ostlund - Craig Hallum Capital Group Marie Thibault - BTIG Yale Jen - Laidlaw & Company David Turkaly - JMP Securities Francois Brisebois - Oppenheimer Frank Takkinen - Lake Street Capital Market Operator Good day and welcome to the iCAD Inc. Fourth Quarter and Full Year 2022 Earnings Call. At this time all participants have been placed on a listen-only mode and we will open the floor for your questions and comments after the presentation.
What type of business is iCAD?
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
What sector is iCAD in?
iCAD is in the Healthcare sector
What industry is iCAD in?
iCAD is in the Medical Devices industry
What country is iCAD from?
iCAD is headquartered in United States
When did iCAD go public?
iCAD initial public offering (IPO) was on 13 December 1984
What is iCAD website?
https://www.icadmed.com
Is iCAD in the S&P 500?
No, iCAD is not included in the S&P 500 index
Is iCAD in the NASDAQ 100?
No, iCAD is not included in the NASDAQ 100 index
Is iCAD in the Dow Jones?
No, iCAD is not included in the Dow Jones index
When does iCAD report earnings?
The next expected earnings date for iCAD is 14 August 2024